Pfizer shares sinking to March 2020 lows after the company halted its twice-daily weight loss pill. Just how big of a setback is this for the pharma heavyweight’s entry into the obesity drug race? The Fast Money traders debate.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
